Madrigal Pharmaceuticals, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Sibold William John President and CEO -7.6K $400.18 -$3.05M
    SEC Kelley Shannon T General Counsel -1.3K $367.81 -$479.62K
    SEC BATE KENNETH N/A -10K $365.20 -$3.65M
    SEC FRIEDMAN PAUL A N/A -129K $370.24 -$47.82M
    SEC FRIEDMAN PAUL A N/A -47K $355.31 -$16.63M
    SEC Taub Rebecca N/A -46K $355.32 -$16.51M
    SEC FRIEDMAN PAUL A N/A -1.4K $350.03 -$490.04K
    SEC Taub Rebecca N/A -1K $350.01 -$350.01K
    SEC FRIEDMAN PAUL A N/A -29K $353.19 -$10.20M
    SEC Taub Rebecca N/A -29K $353.19 -$10.28M
    SEC CRAVES FRED B N/A -15K $328.54 -$5.08M
    SEC Dier Mardi SVP and CFO -258 $323.04 -$83.34K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -14K $341.32 -$4.82M
    SEC Dier Mardi SVP and CFO -2K $324.96 -$637.25K
    SEC Huntsman Carole Chief Commercial Officer -1.8K $325.98 -$597.85K
    SEC Kelley Shannon T General Counsel -415 $335.00 -$139.03K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -1.2K $341.07 -$418.49K
    SEC BATE KENNETH N/A -20K $356.44 -$7.13M
    SEC Daly James M N/A -15K $347.45 -$5.38M
    SEC Huntsman Carole Chief Commercial Officer -347 $335.24 -$116.33K
    SEC Sibold William John President and CEO -1.6K $335.24 -$531.02K
    SEC Taub Rebecca Pres., R&D, and CMO -648 $335.24 -$217.24K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -103 $335.24 -$34.53K
    SEC Kelley Shannon T General Counsel -277 $273.41 -$75.73K
    SEC Taub Rebecca Pres., R&D, and CMO -1.7K $273.41 -$461.79K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -442 $273.41 -$120.85K
    SEC CRAVES FRED B N/A -3.6K $315.31 -$1.14M
    SEC CRAVES FRED B N/A -3.4K $350.30 -$1.19M
    SEC Huntsman Carole Chief Commercial Officer -688 $316.92 -$218.04K
    SEC Levy Richard S N/A -5K $350.00 -$1.75M
    SEC Levy Richard S N/A -5K $300.94 -$1.50M
    SEC Sibold William John President and CEO -6.4K $243.83 -$1.55M
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -1.9K $280.00 -$532.00K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -2K $285.00 -$570.00K
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -1K $231.34 -$239.67K
    SEC CRAVES FRED B N/A -22K $212.88 -$4.79M
    SEC FRIEDMAN PAUL A N/A -26K $246.19 -$6.47M
    SEC Taub Rebecca Pres., R&D, and CMO -2.7K $245.99 -$658.27K
    SEC FRIEDMAN PAUL A N/A -74K $243.93 -$17.98M
    SEC Taub Rebecca Pres., R&D, and CMO -74K $243.92 -$18.02M
    SEC BATE KENNETH N/A -32K $252.85 -$8.21M
    SEC Daly James M N/A -32K $252.97 -$8.22M
    SEC Levy Richard S N/A -11K $257.48 -$2.83M
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -4K $235.50 -$942.00K
    SEC Baker Brothers Life Sciences LP N/A +102K $221.20 +$22.52M
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -3.8K $222.82 -$846.72K
    SEC Baker Brothers Life Sciences LP N/A +35K $218.31 +$7.55M
    SEC Lynch Brian Joseph SVP and General Counsel -2.8K $221.89 -$621.29K
    SEC Lynch Brian Joseph SVP and General Counsel -7K $201.50 -$1.41M
    SEC Baker Brothers Life Sciences LP N/A +64K $188.47 +$12.13M
    SEC Baker Brothers Life Sciences LP N/A +67K $178.11 +$11.95M
    SEC Waltermire Robert E. Senior VP, Chief Pharma Dev. -10K $273.24 -$2.73M
    SEC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP N/A -30K $109.74 -$3.29M
    SEC CRAVES FRED B N/A -30K $109.74 -$3.29M
    SEC BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP N/A -1.2M $105.47 -$126.56M
    SEC CRAVES FRED B N/A -1.2M $105.47 -$126.56M
    SEC MILLIGAN DAVID V N/A -20K $112.54 -$2.25M
    SEC FRIEDMAN PAUL A Chief Executive Officer +4K $117.88 +$471.52K
    SEC CRAVES FRED B N/A +2K $124.69 +$249.38K
    SEC FRIEDMAN PAUL A Chief Executive Officer +4K $124.00 +$496.00K
    SEC MILLIGAN DAVID V N/A -10K $131.60 -$1.32M
    SEC MILLIGAN DAVID V N/A +10K $16.46 +$164.60K
    SEC MILLIGAN DAVID V N/A +20K $9.45 +$189.00K
    SEC BAY CITY CAPITAL LLC N/A -280K $287.46 -$80.49M
    SEC CRAVES FRED B N/A -268K $287.46 -$77.09M
    SEC FRIEDMAN PAUL A Chief Executive Officer -74K $287.46 -$21.14M
    SEC Schneebaum Marc R Chief Financial Officer -2.1K $198.96 -$426.17K
    SEC Taub Rebecca Chief Medical Officer, EVP R&D +74K $287.46 +$21.14M
    SEC Levy Richard S N/A +2K $16.12 +$32.24K
    SEC Levy Richard S N/A +3.6K $16.12 +$57.23K
    SEC Levy Richard S N/A +3.6K $15.88 +$56.37K

    Notifications